Please login to the form below

Living with Crohn's disease: a patient perspective

Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person, and investigates what’s being done to tackle the gaps in treatment options for patients.
What is it like to live with a chronic disease in your 20s? Never knowing when your disease will flare up, what the symptoms will be, or how severely you’ll suffer from them. On top of all this, little is known about your condition so there’s a lack of publicly available information. So, how do you deal with this?

In this article, Account Executive Victoria Morton explores what it’s like to live with Crohn’s disease as a young person and investigate what’s being done to tackle the gaps in treatment options for patients.

Overview of Inflammatory Bowel Disease (IBD) and Crohn’s disease

Not many people know exactly what Crohn’s disease is or how it’s caused. Crohn’s disease is a form of Inflammatory Bowel Disease (IBD), which causes inflammation of the digestive system or gut. It affects approximately 1.3 million people worldwide. Once considered a rare disease in young people, it is now known to be one of the most important chronic diseases affecting children and adolescents. Although Crohn’s disease can start at any age, those diagnosed are commonly teenagers and young adults who are in the prime of life. On top of this, younger people are more likely to suffer from severe symptoms, and as the severity of symptoms worsen, the number and complexity of these symptoms also increases.

When you think of Crohn’s disease, you may think of rushing to the toilet, but the reality is very different. Patients can experience a variety of symptoms depending on where in the gut the disease is active, ranging from mild to severe. It’s also a very individual condition. The most common symptoms are not only diarrhoea, but also tiredness and fatigue, abdominal pain, mouth ulcers, anaemia, loss of appetite, and weight loss. In addition, patients with severe symptoms also suffer an increased range of features of their condition, such as intestinal inflammation. Symptoms are unpredictable and affect everyday living, significantly impacting on quality of life. Not something you want to be dealing with when you’re trying to study for exams or training for that big rugby game.

Living with Crohn’s: challenges in diagnosis

Our understanding of the causes of Crohn’s disease is improving. There isn’t one definitive cause of Crohn’s disease, and evidence suggests that a combination of inappropriate immune response, genetic susceptibility, and environmental risk factors (such as smoking and stress) may contribute to disease development (Gyires, 2014).

Despite progression in our knowledge of this condition, there is still a relatively poor understanding of this complex disease area, which inherently makes diagnosis even more difficult. Diagnosis can take up to three years due to delayed presentation of symptoms and misdiagnosis. This increases the time before patients can start managing their symptoms and begin to feel better.
 

Download the full article from Blue Latitude Health

24th November 2016

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

Diagnosing the lag in neuropsychiatric treatments
The number of mental health research programmes in larger drug firms has shrunk by 70% in the past decade. Blue Latitude Health Senior Associate Consultant Sana Rahim explores this drop in investment and explains why developing a market-orientated model is vital for making progress.
Blue Latitude Health
Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking CAR-T therapy for the first patient in Europe, and how the centre of excellence has adapted to make precision medicine a reality
Blue Latitude Health
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market.
Blue Latitude Health
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives his side of the story and explains how industry can help oncologists treat more patients with targeted therapies.
Blue Latitude Health
Battling breast cancer with precision medicine (Part 1)
Laura Holmes Haddad is a breast cancer survivor. She made the incredibly brave decision to participate in a PARP inhibitor precision medicine trial. Here, the author and precision medicine advocate tells her story and explains what industry needs to remember when treating cancer patients with precision medicine.
Blue Latitude Health
The role of brain health in treating MS
Blue Latitude Health speaks to Professor Gavin Giovannoni, key opinion leader and Chair of Neurology, Barts and The London School of Medicine and Dentistry, about his theories on brain health, the importance of a holistic approach to MS and why digital technology is the future of effective MS care.
Blue Latitude Health